AMERICAN BIO MEDICA CORP - FORM 10-Q - EX-32 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - September 15, 2020

Attached files

file filename
EX-31 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - AMERICAN BIO MEDICA CORPabmc_ex31.htm
10-Q - QUARTERLY REPORT - AMERICAN BIO MEDICA CORPabmc_10q.htm
 
Exhibit 32.1/Exhibit 32.2
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
         In connection with the Quarterly Report of American Bio Medica Corporation (the “Company”) on Form 10-Q for the period ending June 30, 2020 as filed with the Securities and Exchange Commission on September 15, 2020 (the “Report”), I, Melissa A. Waterhouse, Chief Executive Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ Melissa A. Waterhouse                                                      
Melissa A. Waterhouse
Chief Executive Officer (Principal Executive Officer) Principal Financial Officer
Principal Accounting Officer
 
September 15, 2020
 
 
 

AMERICAN BIO MEDICA CORP Reports